Difficulty: Medium
Average Score: 86%
Practice
Which type of leukemia has been MOST likely developed in a 2-year-old child with Down syndrome in the neonatal period?
Correct answer
D
Rationale
In this scenario, the correct answer is D) AML M6. The rationale behind this is that children with Down syndrome have a higher risk of developing Acute Myeloid Leukemia (AML) compared to Acute Lymphoblastic Leukemia (ALL) or Chronic Myeloid Leukemia (CML).
AML M6, also known as acute megakaryoblastic leukemia, is a type of AML that is more commonly associated with Down syndrome. This specific subtype of AML is characterized by the proliferation of abnormal megakaryoblasts in the bone marrow.
Option A) ALL is less likely in this case because children with Down syndrome are more predisposed to AML. Option B) CML is a chronic leukemia and is less common in pediatric patients, especially those with Down syndrome. Option C) AML M1 is another subtype of AML but is not as commonly associated with Down syndrome as AML M6.
Educationally, understanding the association between Down syndrome and different types of leukemia is crucial for pediatric nurses as it helps in early detection, appropriate management, and providing comprehensive care to these vulnerable patients. This knowledge also highlights the importance of tailored screening protocols and close monitoring for children with Down syndrome to detect any signs of leukemia early on.
AML M6, also known as acute megakaryoblastic leukemia, is a type of AML that is more commonly associated with Down syndrome. This specific subtype of AML is characterized by the proliferation of abnormal megakaryoblasts in the bone marrow.
Option A) ALL is less likely in this case because children with Down syndrome are more predisposed to AML. Option B) CML is a chronic leukemia and is less common in pediatric patients, especially those with Down syndrome. Option C) AML M1 is another subtype of AML but is not as commonly associated with Down syndrome as AML M6.
Educationally, understanding the association between Down syndrome and different types of leukemia is crucial for pediatric nurses as it helps in early detection, appropriate management, and providing comprehensive care to these vulnerable patients. This knowledge also highlights the importance of tailored screening protocols and close monitoring for children with Down syndrome to detect any signs of leukemia early on.